{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"PepGen Inc."},"Symbol":{"label":"Symbol","value":"PEPG"},"Address":{"label":"Address","value":"245 MAIN STREET 8TH FLOOR, CAMBRIDGE, Massachusetts, 02142, United States"},"Phone":{"label":"Phone","value":"+1 781 797-0979"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.pepgen.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"James Gregg McArthur","title":"President, Chief Executive Officer & Director"},{"name":"Michelle L. Mellion","title":"Chief Medical Officer"},{"name":"Paul D. Streck","title":"Executive VP, Head-Research & Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}